Intensity-Modulated Radiation Therapy News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Many Mesothelioma Centers Top List of Best Cancer Hospitals
The University of Texas MD Anderson Cancer Center retained its standing as the top cancer care hospital in the nation for the second consecutive year, according to U.S. News & World Report.
The publication’s 2016-17 Best Hospitals for Cancer graded cancer centers from 0-100 on a variety of categories such as reputation with specialists, volume of high-risk patients, patient survival and safety, nurse intensity and advanced technologies.
The purpose: Help patients make more informed health care decisions.
“It’s important for patients to know that not all hospitals deliver equivalent levels of care,” Ben Hard...
Source: Asbestos and Mesothelioma News - August 11, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: best cancer centers best cancer hospitals best hospitals for cancer best hospitals rankings best mesothelioma cancer centers md anderson cancer center mesothelioma treatment moffitt cancer center us news and world report best hospitals Source Type: news
Accuray wins FDA nod for Radixact image-guided radiotherapy
Accuray (NSDQ:ARAY) said today it won FDA 510(k) clearance for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments designed for cancer patients.
The company said it also won FDA clearance for its Accuray Precision treatment planning system and iDMS data management system, components of its Radixact treatment platform.
“The Radixact system builds upon the unique strengths of the TomoTherapy platform. Expanded delivery capabilities enable treatment with image-guided, intensity-modulated radiation therapy to an expanded range of patients. New database features make the ring gantry...
Source: Mass Device - June 27, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Radiosurgery Regulatory/Compliance Accuray Inc. Source Type: news
Finally, RCT Results for Proton Therapy in a CancerFinally, RCT Results for Proton Therapy in a Cancer
Results from the first randomized controlled trial of proton therapy indicate that the new technology is no better than IMRT in the treatment of lung cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 21, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Study finds adaptive IGRT for bladder preservation clinically feasible
(American Society for Radiation Oncology) A prospective study examining a trimodality treatment approach in localized bladder cancer cases using adaptive image-guided, intensity-modulated radiation therapy (IG-IMRT) found that the bladder preservation rate at three years was 83 percent. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 29, 2016 Category: Cancer & Oncology Source Type: news
New Elekta iViewDose Software Designed to Provide an Essential Safety Check for Radiation Therapy
EPID-based in vivo patient dosimetry for error detection receives US FDA 510(k) clearance and CE Mark
CRAWLEY, England, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- The use of highly-focused, rapid delivery techniques such as intensity mo... Devices, Oncology, Product LaunchElekta, iViewDose, dosimetry, IMRT, VMAT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 1, 2016 Category: Pharmaceuticals Source Type: news
Experience Can Count in Radiation for Head-and-Neck CancerExperience Can Count in Radiation for Head-and-Neck Cancer
Head-and-neck cancer (HNC) patients treated with intensity modulated radiotherapy (IMRT) do better when radiation oncologists are more experienced, according to U.S. and Chinese researchers. Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - January 12, 2016 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Diagnosed With Prostate Cancer, Now What: A New Study Shows That Surgery Is the Best Option
With prostate cancer being one of the leading cancers in men, finding the best way to treat it has become increasingly important. A new study points to why surgery might be the best long term treatment option, especially for men with localized prostate cancer. Researchers from Odette Caner Centre, Sunnybrook Research Institute (University of Toronto, Canada) conducted a meta-analysis of 19 studies comparing the success/survival rates of surgery vs. radiation. All in all, this added up to about 120,000 men who received either surgery or radiation as treatment for their localized prostate cancer. What researchers found was...
Source: Healthy Living - The Huffington Post - December 17, 2015 Category: Consumer Health News Source Type: news
SMART Approach Is Advancing Mesothelioma Survival Rates
Accelerated high-dose radiation just before extrapleural pneumonectomy (EPP) surgery — a reversal of the traditional order at most U.S. specialty centers — continues to produce impressive results for pleural mesothelioma patients in Toronto.
Specialists at the Princess Margaret Cancer Centre and Toronto General Hospital estimated the median overall survival and disease-free survival at 51 and 47 months, respectively, for patients with the most common subtype of the disease.
Surgeon Marc de Perrot presented the findings of an ongoing study earlier this year at the American Association for Thoracic Surgery in Seattle. ...
Source: Asbestos and Mesothelioma News - December 14, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news
Nestor Villamizar Grows Mesothelioma Program in Miami
Thoracic surgeon Nestor Villamizar saw the glaring need for a comprehensive mesothelioma program in bustling South Florida, even when he was 1,500 miles away in Boston.
He is filling that void today.
Villamizar joined the Sylvester Comprehensive Cancer Center in 2014, hoping to slow the stream of mesothelioma patients who are leaving Florida to seek treatment at Brigham and Women's Hospital in Boston.
He has been a much-welcomed addition to the state. The early results are impressive.
"When I was working at the Brigham, we kept seeing more and more mesothelioma patients coming for surgery from Florida, and it always k...
Source: Asbestos and Mesothelioma News - December 3, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news
Cost to treat low-risk prostate cancer can vary widely, UCLA study finds
How much does it actually cost to treat low-risk prostate cancer?
A team of UCLA researchers are the first to describe the cost throughout the entire process for men being treated for low-risk prostate cancer — from their first appointment to post-treatment follow-up testing.
Analyzing several different types of cancer treatment that were available throughout the entire 12-year study period, the researchers found a wide variance in costs. The research indicates that there may be a better way to monitor costs and keep them in check for patients, said Dr. Aaron Laviana, the study’s first author.
“As we move from tradit...
Source: UCLA Newsroom: Health Sciences - November 3, 2015 Category: Universities & Medical Training Source Type: news
'No Brainer': IMRT for Locally Advanced NSCLC 'No Brainer': IMRT for Locally Advanced NSCLC
Intensity-modulated radiotherapy (IMRT) is associated with fewer adverse events than standard radiotherapy and should now be considered routinely, say researchers. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 24, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
IMRT Reduces Toxicity in Unresectable NSCLC (CME/CE)
(MedPage Today) -- Survival similar to 3D-CRT with less lung, heart toxicity (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 21, 2015 Category: Hematology Source Type: news
ASTRO: Shorter RT works for low-risk prostate cancer
Hypofractionated radiation therapy (RT) yields similar rates of cure and side...Read more on AuntMinnie.comRelated Reading:
Shortened RT for prostate cancer may not be better
Prostate cancer rad therapy may cause other cancers
Proton therapy succeeds in treating prostate cancer
NEJM: Urologist self-referral equals IMRT overuse
Prostate cancer patients get too much radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2015 Category: Radiology Source Type: news
Shortened RT for prostate cancer may not be better
Hypofractionated radiation therapy (RT) isn't necessarily better for prostate...Read more on AuntMinnie.comRelated Reading:
Prostate cancer rad therapy may cause other cancers
Proton therapy succeeds in treating prostate cancer
NEJM: Urologist self-referral equals IMRT overuse
Prostate cancer patients get too much radiation therapy
Proton therapy groups praise GAO prostate cancer report (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 19, 2015 Category: Radiology Source Type: news
For lung cancer patients, IMRT associated with lesser side effects, better tolerance of chemotherapy, compared to conventional radiation therapy
An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer (NSCLC) has shown that those who received intensity modulated radiation therapy (IMRT) had less severe lung toxicity and were able to better tolerate their chemotherapy, compared to patients who received 3-dimensional conformal radiation therapy (3-D CRT). (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 19, 2015 Category: Cancer & Oncology Source Type: news
